X4 Pharmaceuticals, Inc. Common Stock (XFOR)

Typically moves ±12.68% on earnings
EARNINGS ANALYTICS
search

X4 Pharmaceuticals, Inc. Common Stock (XFOR) has a 17-report earnings history dating back to Aug 03, 2021. Its average absolute post-earnings move is ±12.68%, and 35.3% of those reactions were positive. Its largest post-earnings gain was +32% (Mar 21, 2024) and its largest decline was -55.24% (Nov 13, 2024).

Earnings reactions

How XFOR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

17

Avg Abs. Movement

±12.68%

Positive %

35.3%

Negative %

64.7%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Nov 05, 2025 ☀ PRE -10.13% open_in_new
May 01, 2025 ☀ PRE -11.46% open_in_new
Mar 25, 2025 ☀ PRE -12.66% open_in_new
Nov 13, 2024 ☀ PRE -55.24% open_in_new
event

Earnings Count

17

Total earnings in dataset

trending_up

Avg Abs. Movement

±12.68%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 11 →
11
Funds holding
$61996150
Total value held
Buying
8 added · 1 reduced
Morgan Stanley
$39098676 +15.34%
Blackstone Inc.
$11076338 NEW BUY
Blackrock, Inc.
$5004710 -1.22%
Goldman Sachs Group Inc
$3643213 +6.04%
State Street Corp
$1666595 +103.56%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
3 20260701 open_in_new SEC.gov
4 20260701 open_in_new SEC.gov
4 20260701 open_in_new SEC.gov
8-K 20260701 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
EFFECT 20260514 open_in_new SEC.gov
4 20260513 open_in_new SEC.gov
8-K/A 20260513 open_in_new SEC.gov
CORRESP 20260512 open_in_new SEC.gov
UPLOAD 20260511 open_in_new SEC.gov

Frequently asked about XFOR earnings

How much does XFOR stock move after earnings? expand_more

Over 17 reports, XFOR has moved an average of ±12.68% the session after earnings, closing higher 35.3% of the time.

What was XFOR's biggest post-earnings move? expand_more

XFOR's largest post-earnings gain on record was +32% on Mar 21, 2024, and its largest decline was -55.24% on Nov 13, 2024.

Where can I find X4 Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more

All of X4 Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers